Tag: Agios Pharmaceuticals

Biotech, Industry

‘Flat is the new up’: After biotech correction, venture investors turn to safer bets

July 26, 2022

Via: Biopharma Dive

Agios Pharmaceuticals needed money. It was 2010 and Agios, like many other biotechnology startups then, was trying to survive following a global recession. Venture capital was contracting, leaving emerging companies with fewer financing options. Initial public offerings, a main source of […]